Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
- Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1)
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
ON-DEMAND WEBINARS
How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?
Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.
An expert panel explores how the industry leverages digital innovation to manage immunotherapy risks and critical next steps toward deploying scalable, technology-driven CRS monitoring solutions.
Join the Co-CEO of CRIO, as he explores research site challenges and how site-based technologies can reduce administrative burdens, enhance efficiency, and eliminate redundant one-time-use technologies.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![doctors laptop iStock-1196710776]( "Reduce Time, Cost, & Risk With Clinical Study Data Review Software")
Reduce Time, Cost, & Risk With Clinical Study Data Review SoftwareSee how a top 10 global biopharmaceutical company implemented a single data review system to reduce the time, cost, and risk of running its clinical trials while accelerating the time to market.
-
![Doctor Clinical Trial]( "IRT? RTSM? What's The Difference?")
IRT? RTSM? What's The Difference?What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
![Wearable iStock-1257436276]( "7 eCOA Design Recommendations: Insights From Sites And CRAs")
7 eCOA Design Recommendations: Insights From Sites And CRAsSignant joined a group of C-Path members including other eCOA solution providers, sponsors, and regulators for a GBTI project that revealed several opportunities to improve eCOA usability and flexibility.
-
![Risk-GettyImages-1364371014]( "How Long Is Your RTSM Risk Mitigation List?")
How Long Is Your RTSM Risk Mitigation List?While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
-
![wearables-work-best-when-GettyImages-1402123061]( "When To Use Wearables In A Clinical Trial And How to Get Started")
When To Use Wearables In A Clinical Trial And How to Get StartedWearables work best when they close real measurement gaps — from irregular symptoms to mobility and sleep. In a unified data environment, they deliver richer insights without added complexity.
-
![Nurse patient checking medical exams-GettyImages-1487540665]( "The Future Of Remote Patient Monitoring In Decentralized Clinical Trials")
The Future Of Remote Patient Monitoring In Decentralized Clinical TrialsRemote Patient Monitoring (RPM) is not just an innovation—it's a catalyst redefining how clinical research is conducted in the digital age.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
![trends-for-2025-GettyImages-2161094939]( "Trends In Clinical Trials In 2025: Navigating A Transformative Landscape")
Trends In Clinical Trials In 2025: Navigating A Transformative LandscapeIn 2025, it is likely the clinical trial landscape will be shaped by advancements in artificial intelligence (AI), evolving recruitment strategies, and a renewed focus on equitable access.
-
![Nurse patient checking medical exams-GettyImages-1487540665]( "How Pfizer Used Wearable DHTs To Reveal Meaningful Treatment Effects In Cancer Cachexia")
How Pfizer Used Wearable DHTs To Reveal Meaningful Treatment Effects In Cancer CachexiaWearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.
-
![Removing translation]( "Removing Translation Bottlenecks With AI")
Removing Translation Bottlenecks With AISee how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.
FROM THE EDITOR
- Telehealth In Clinical Trials: What Sites And Patients Think
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders